PharmaBoardroom

Clarence Ngui – Regional VP, Medical Education, Asia…

Clarence Ngui describes how global orthopaedic product giant Zimmer Biomet has pivoted in APAC in response to the COVID-19 pandemic; how medical…

Top 10 Pharma Companies in Canada Ranking 2020

The Top 10 companies in the Canadian pharma market for 2020, ranked by revenues in USD billions. J&J takes the top spot with USD 3.46 billion,…

Lonza Goes Big with Swiss Investments in Biologics, ADCs &…

In the last month alone, CDMO giant Lonza has announced three major upgrades to its manufacturing footprint in Visp, Western Switzerland: a huge…

Top Pharma Markets in Asia-Pacific Ranking

The Top 10 pharma markets in the vast Asia-Pacific region, ranked by market size in USD millions for 2018. China is way out in front with a market…

APAC: How Precision Medicine is Transforming the Oncology…

Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year and with deaths caused by cancer expected to increase by 36 percent by…

China: EpimAb Looks to 2022 IPO & Global Leadership in…

Hot on the heels of a USD 120 million fundraising round, Shanghai-based EpimAb Biotherapeutics is now looking towards a 2022 IPO with the aim of…

Politics and Pharma M&A in Argentina

The COVID-19 pandemic has caused economic and social disruption and affected the behaviour of both consumers and producers in Argentina, with an…

Guillermo Frydman – Managing Director, J&J Singapore

J&J Singapore's Guillermo Frydman outlines how his affiliate negotiated the COVID-19 pandemic; why managing J&J's pharma, medical devices,…

Georg Boonen – CEO, Max Zeller

Georg Boonen, CEO of Switzerland’s leading phytopharmaceutical player Max Zeller, discusses the company’s expanded market position at home and…

Litigation: Croatia

Key legal info on litigation in Croatia. Prepared in association with Danijel Pribanić, a leading global law firm, this is an extract from The Pharma…

Spanish Pharma News: Market Growth; Esteve’s US Expansion; PTS…

The latest from Spanish pharma, including the acquisition of PTS by a private equity group for its nanoparticle drug delivery technologies; the…

US U-Turn as Biden Pledges Support for Waiver on COVID-19 Vaccine…

In a shock move, Joe Biden’s administration looks set to support a waiver on intellectual property (IP) protections for COVID-19 vaccines.…

Tagged with R